Biocon Limited announced that its wholly-owned subsidiary, Biocon Generics Inc., has acquired Eywa Pharma Inc.’s oral solid dosage manufact...

Lupin's Nagpur facility has received two observations from the USFDA through Form-483 due to violations of the Food Drug and Cosmetic (FD&C...

A press release from the city-based drug maker said Lighthouses are factories leading the way in Fourth Industrial Revolution (Industry 4.0...

Suven will purchase100% of share capital from CPPL existing investors. Suven didn't provide details like annual turnover of the acquired as...

The site has received certifications from the Food and Drug Administration (FDA) and European Medicines Agency (EMA), it added.

"The inspection closed with two 483 observations," Lupin said.

USFDA conducted the inspection between August 5-8, 2019, Lupin said in a filing to the BSE.

Lupin said the observations are "largely procedural in nature with some gaps identified in the aseptic processing areas of the Cephalospori...

"The company's Oral Solid Dosage drug manufacturing plant located at SEZ, Ahmedabad has received an Establishment Inspection Report (EIR) f...

The stock soared 11 per cent to settle at Rs 296.75 on BSE. During the day, it jumped 17.44 per cent to Rs 314.

Indoco Remedies today said it has received an approval from the US Food and Drug Administration (USFDA) for its solid dosages manufacturing...

This will enable the company to commercialise oral solid dosage formulations in the US market from this manufacturing facility.

Vivimed Labs today said it has acquired a manufacturing facility of Actavis Pharma Manufacturing Ltd for a total consideration of Rs 122 cr.

The company's net sales for the quarter stood at Rs 173.98 crore, registering a growth of 65 per cent, as against Rs 105.6 crore in year-ag...

Jubilant Life Sciences said it has received approvals from the US health regulator for 4 products that target CNS and CVS therapeutic areas.

Zydus Cadila today said the USFDA has given the green signal for commencement of drug supplies to the US from its plant at Himachal Pradesh.

Drug maker Panacea Biotec on Friday said its pharmaceutical facility at Baddi in Himachal Pradesh has received approval from US health regu...